Seacoast Capital Invests $30M in SkinCure Oncology

September 24, 2019

Seacoast Capital announced a $30 million syndicated growth equity investment in SkinCure Oncology, a Burr Ridge, Illinois-based provider of turnkey image-guided superficial radiation therapy (IG-SRT) services for dermatologists. The non-control capital infusion was used to facilitate a shareholder dividend and to capitalize SkinCure for future growth and national expansion.

Buyers
Seacoast Capital
Targets
SkinCure Oncology
Location
Illinois, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.